0 Replies
Onsdag d. 19. december, 2007 London, UK & København, Danmark: GlaxoSmithKline (GSK) og Santaris Pharma meddeler, at de har indgået en verdensomspændende strategisk alliance med henblik på at identificere, udvikle og markedsføre nye lægemidler mod virussygdomme. Samarbejdet giver GSK adgang til patenterede RNA antagonist lægemiddelkandidater, som er baseret på Santaris Pharmas... Contine Reading & Discuss→
0 Replies
Wednesday December 19, 2007 London, UK & Copenhagen, Denmark: GlaxoSmithKline (GSK) and Santaris Pharma today announced that they have entered into a worldwide strategic alliance for the discovery, development and commercialisation of novel medicines against viral diseases. The collaboration provides GSK access to patented RNA antagonist compounds, based on Santaris Pharma’s... Contine Reading & Discuss→
0 Replies
Gilde Healthcare Partners joins existing shareholders, board directors and management in the Company’s Series C Investment Round
read more Contine Reading & Discuss→
0 Replies
Gilde Healthcare Partners går sammen med eksisterende aktionærer, bestyrelsesmedlemmer og ledelse i Santaris Pharmas Serie C investeringrunde
read more Contine Reading & Discuss→
